{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:10:15Z","timestamp":1793113815048,"version":"4.5.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,5]],"date-time":"2007-01-05T00:00:00Z","timestamp":1167955200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2007,2,15]]},"DOI":"10.1007\/s00213-006-0644-4","type":"journal-article","created":{"date-parts":[[2007,1,5]],"date-time":"2007-01-05T03:08:16Z","timestamp":1167966496000},"page":"67-86","source":"Crossref","is-referenced-by-count":51,"title":["The pharmacological management of childhood anxiety disorders: a review"],"prefix":"10.1007","volume":"191","author":[{"given":"Shauna P.","family":"Reinblatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Riddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,5]]},"reference":[{"key":"644_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0887-6185(98)00036-X","volume":"12","author":"MV Abene","year":"1998","unstructured":"Abene MV, Hamilton JD (1998) Resolution of fear of flying with fluoxetine treatment. J Anxiety Disord 12:599\u2013603","journal-title":"J Anxiety Disord"},{"key":"644_CR2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/01.chi.0000155320.52322.37","volume":"44","author":"H Abikoff","year":"2005","unstructured":"Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L (2005) Sequential pharmacotherapy for children with comorbid attention-deficit\/hyperactivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry 44:418\u2013427","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00004583-199503000-00020","volume":"34","author":"TM Achenbach","year":"1995","unstructured":"Achenbach TM, Howell CT, McConaughy SH, Stanger C (1995) Six-year predictors of problems in a national sample of children and youth: I. Cross-informant syndromes. J Am Acad Child Adolesc Psychiatry 34:336\u2013347","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1192\/bjp.179.1.15","volume":"179","author":"C Allgulander","year":"2001","unstructured":"Allgulander C, Hackett D, Salinas E (2001) Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study. Br J Psychiatry 179:15\u201322","journal-title":"Br J Psychiatry"},{"key":"644_CR5","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1176\/appi.ajp.161.9.1642","volume":"161","author":"C Allgulander","year":"2004","unstructured":"Allgulander C, Dahl AA, Austin C, Morris PL, Sogaard JA, Fayyad R, Kutcher SP, Clary CM (2004) Efficacy of sertraline in a 12-week trial for generalized anxiety disorder. Am J Psychiatry 161:1642\u20131649","journal-title":"Am J Psychiatry"},{"key":"644_CR6","unstructured":"American Medical Association (2001) International classification of diseases, 9th revision, clinical modification physician ICD-9-CM, 2002, vol 1 and 2. AMA Press, Chicago, IL (color-coded, illustrated, annotated)"},{"key":"644_CR7","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1980","unstructured":"American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Association, Washington, DC","edition":"3"},{"key":"644_CR8","volume-title":"American Psychiatric Association practice guidelines for the treatment of psychiatric disorders: Compendium 2000","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) American Psychiatric Association practice guidelines for the treatment of psychiatric disorders: Compendium 2000. American Psychiatric Association, Washington, DC"},{"key":"644_CR9","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1176\/ajp.150.12.1779","volume":"150","author":"A Angold","year":"1993a","unstructured":"Angold A, Costello EJ (1993) Depressive comorbidity in children and adolescents: empirical, theoretical, and methodological issues. Am J Psychiatry 150:1779\u20131791","journal-title":"Am J Psychiatry"},{"key":"644_CR10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1461145702003127","volume":"5","author":"R Balon","year":"2002","unstructured":"Balon R (2002) Emotional blunting, sexual dysfunction and SSRIs. Int J Neuropsychopharmacol 5:415\u2013416","journal-title":"Int J Neuropsychopharmacol"},{"key":"644_CR11","first-page":"341","volume-title":"Pediatric psychopharmacology: principles and practice","author":"SR Barnett","year":"2003","unstructured":"Barnett SR, Riddle MA (2003) Anxiolytics: benzodiazepines, buspirone, and others. In: Martin A, Scahill L, Charney D, Leckman J (eds) Pediatric psychopharmacology: principles and practice. Oxford University Press, New York, pp 341\u2013351"},{"key":"644_CR12","first-page":"762","volume":"30","author":"L Barrickman","year":"1991","unstructured":"Barrickman L, Noyes R, Kuperman S, Schumacher E, Verda M (1991) Treatment of ADHD with fluoxetine: a preliminary trial. J Am Acad Child Adolesc Psychiatry 30:762\u2013767","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002130000372","volume":"149","author":"J Benjamin","year":"2000","unstructured":"Benjamin J, Ben Zion IZ, Karbofsky E, Dannon P (2000) Double-blind placebo-controlled pilot study of paroxetine for specific phobia. Psychopharmacology (Berl) 149:194\u2013196","journal-title":"Psychopharmacology (Berl)"},{"key":"644_CR14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.138.2.110","volume":"138","author":"T Berney","year":"1981","unstructured":"Berney T, Kolvin I, Bhate SR, Garside RF, Jeans J, Kay B, Scarth L (1981) School phobia: a therapeutic trial with clomipramine and short-term outcome. Br J Psychiatry 138:110\u2013118","journal-title":"Br J Psychiatry"},{"key":"644_CR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00004583-199101000-00007","volume":"30","author":"GA Bernstein","year":"1991","unstructured":"Bernstein GA (1991) Comorbidity and severity of anxiety and depressive disorders in a clinic sample. J Am Acad Child Adolesc Psychiatry 30:43\u201350","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR16","doi-asserted-by":"crossref","first-page":"69S","DOI":"10.1097\/00004583-199710001-00006","volume":"36","author":"GA Bernstein","year":"1997","unstructured":"Bernstein GA, Shaw K (1997) Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 36:69S\u201384S","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00004583-199009000-00016","volume":"29","author":"GA Bernstein","year":"1990","unstructured":"Bernstein GA, Garfinkel BD, Borchardt CM (1990) Comparative studies of pharmacotherapy for school refusal. J Am Acad Child Adolesc Psychiatry 29:773\u2013781","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00004583-200003000-00008","volume":"39","author":"GA Bernstein","year":"2000","unstructured":"Bernstein GA, Borchardt CM, Perwien AR, Crosby RD, Kushner MG, Thuras PD, Last CG (2000) Imipramine plus cognitive\u2013behavioral therapy in the treatment of school refusal. J Am Acad Child Adolesc Psychiatry 39:276\u2013283","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00004583-200102000-00015","volume":"40","author":"GA Bernstein","year":"2001","unstructured":"Bernstein GA, Hektner JM, Borchardt CM, McMillan MH (2001) Treatment of school refusal: one-year follow-up. J Am Acad Child Adolesc Psychiatry 40:206\u2013213","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/ajp.148.5.564","volume":"148","author":"J Biederman","year":"1991","unstructured":"Biederman J, Newcorn J, Sprich S (1991) Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148:564\u2013577","journal-title":"Am J Psychiatry"},{"key":"644_CR21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00004583-199702000-00012","volume":"36","author":"J Biederman","year":"1997","unstructured":"Biederman J, Faraone SV, Marrs A, Moore P, Garcia J, Ablon S, Mick E, Gershon J, Kearns ME (1997) Panic disorder and agoraphobia in consecutively referred children and adolescents. J Am Acad Child Adolesc Psychiatry 36:214\u2013223","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/med:psych\/9780195135947.003.0011","volume-title":"Phobic and anxiety disorders in children and adolescents: a clinician\u2019s guide to effective psychosocial and pharmacological interventions","author":"B Birmaher","year":"2004","unstructured":"Birmaher B, Ollendick TH (2004) Childhood-Onset Panic Disorder. In: Ollendick TH, March JS (eds) Phobic and anxiety disorders in children and adolescents: a clinician\u2019s guide to effective psychosocial and pharmacological interventions. Oxford University Press, Oxford, pp 306\u2013333"},{"key":"644_CR23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.CHI.0000037049.04952.9F","volume":"42","author":"B Birmaher","year":"2003","unstructured":"Birmaher B, Axelson DA, Monk K, Kalas C, Clark DB, Ehmann M, Bridge J, Heo J, Brent DA (2003) Fluoxetine for the treatment of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 42:415\u2013423","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR24","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/00004583-199211000-00015","volume":"31","author":"B Black","year":"1992","unstructured":"Black B, Uhde TW (1992) Elective mutism as a variant of social phobia. J Am Acad Child Adolesc Psychiatry 31:1090\u20131094","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR25","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00004583-199409000-00010","volume":"33","author":"B Black","year":"1994","unstructured":"Black B, Uhde TW (1994) Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 33:1000\u20131006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00004714-199208000-00022","volume":"12","author":"B Black","year":"1992","unstructured":"Black B, Uhde TW, Tancer ME (1992) Fluoxetine for the treatment of social phobia. J Clin Psychopharmacol 12:293\u2013295","journal-title":"J Clin Psychopharmacol"},{"key":"644_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0193-953X(05)70209-4","volume":"24","author":"O Brawman-Mintzer","year":"2001","unstructured":"Brawman-Mintzer O (2001) Pharmacologic treatment of generalized anxiety disorder. Psychiatr Clin North Am 24:119\u2013137","journal-title":"Psychiatr Clin North Am"},{"key":"644_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004583-199502000-00016","volume":"34","author":"DA Brent","year":"1995","unstructured":"Brent DA, Perper JA, Moritz G, Liotus L, Richardson D, Canobbio R, Schweers J, Roth C (1995) Posttraumatic stress disorder in peers of adolescent suicide victims: predisposing factors and phenomenology. J Am Acad Child Adolesc Psychiatry 34:209\u2013215","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00004583-198909000-00009","volume":"28","author":"DP Cantwell","year":"1989","unstructured":"Cantwell DP, Baker L (1989) Stability and natural history of DSM-III childhood diagnoses. J Am Acad Child Adolesc Psychiatry 28:691\u2013700","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/cap.1999.9.293","volume":"9","author":"JS Carlson","year":"1999","unstructured":"Carlson JS, Kratochwill TR, Johnston HF (1999) Sertraline treatment of 5 children diagnosed with selective mutism: a single-case research trial. J Child Adolesc Psychopharmacol 9:293\u2013306","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"644_CR31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0272-7358(94)90012-4","volume":"14","author":"DB Clark","year":"1994","unstructured":"Clark DB, Smith MG, Neighbors BD, Skerlec LM, Randall J (1994) Anxiety disorders in adolescence: characteristics, prevalence, and comorbidities. Clin Psychol Rev 14:113\u2013137","journal-title":"Clin Psychol Rev"},{"key":"644_CR32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00004714-198308000-00003","volume":"3","author":"B Coffey","year":"1983","unstructured":"Coffey B, Shader RI, Greenblatt DJ (1983) Pharmacokinetics of benzodiazepines and psychostimulants in children. J Clin Psychopharmacol 3:217\u2013225","journal-title":"J Clin Psychopharmacol"},{"key":"644_CR33","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Erlbaum, Hillsdale, NJ","edition":"2"},{"key":"644_CR34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/med:psych\/9780195135947.003.0014","volume-title":"Phobic and anxiety disorders in children and adolescents: a clinician\u2019s guide to effective psychosocial and pharmacological interventions","author":"JA Cohen","year":"2004","unstructured":"Cohen JA, Mannarino AP (2004) Posttraumatic stress disorder. In: Ollendick TH, March JS (eds) Phobic and anxiety disorders in children and adolescents: a clinician\u2019s guide to effective psychosocial and pharmacological interventions. Oxford University Press, Oxford, pp 405\u2013432"},{"key":"644_CR35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00004583-200105000-00016","volume":"5","author":"SN Compton","year":"2001","unstructured":"Compton SN, Grant PF, Chrisman AK, Gammon PJ, Brown VL, March JS (2001) Sertraline in children and adolescents with social anxiety disorder: an open trial. J Am Acad Child Adolesc Psychiatry 5:564","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR36","first-page":"109","volume-title":"Anxiety disorders in children and adolescents","author":"EJ Costello","year":"1995","unstructured":"Costello EJ Angold A (1995) Epidemiology. In: March JS (ed) Anxiety disorders in children and adolescents. Guilford Press, New York, pp 109\u2013124"},{"key":"644_CR37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/da.10146","volume":"19","author":"JR Davidson","year":"2004","unstructured":"Davidson JR, Bose A, Korotzer A, Zheng H (2004) Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study. Depress Anxiety 19:234\u2013240","journal-title":"Depress Anxiety"},{"key":"644_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004583-199201000-00008","volume":"31","author":"J DeVeaugh-Geiss","year":"1992","unstructured":"DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R, Greist JH, Reichler R, Katz R, Landau P (1992) Clomipramine hydrochloride in childhood and adolescent obsessive\u2013compulsive disorder\u2014a multicenter trial. J Am Acad Child Adolesc Psychiatry 31:45\u201349","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR39","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/00004583-200008000-00003","volume":"39","author":"SE Domon","year":"2000","unstructured":"Domon SE, Andersen MS (2000) Nefazodone for PTSD. J Am Acad Child Adolesc Psychiatry 39:942\u2013943","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR40","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1097\/00004583-199511000-00008","volume":"34","author":"HM Douglass","year":"1995","unstructured":"Douglass HM, Moffitt TE, Dar R, McGee R, Silva P (1995) Obsessive\u2013compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. J Am Acad Child Adolesc Psychiatry 34:1424\u20131431","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR41","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00004583-199605000-00016","volume":"35","author":"ES Dummit III","year":"1996","unstructured":"Dummit ES III, Klein RG, Tancer NK, Asche B, Martin J (1996) Fluoxetine treatment of children with selective mutism: an open trial. J Am Acad Child Adolesc Psychiatry 35:615\u2013621","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/cap.1997.7.17","volume":"7","author":"JM Fairbanks","year":"1997","unstructured":"Fairbanks JM, Pine DS, Tancer NK, Dummit ES III, Kentgen LM, Martin J, Asche BK, Klein RG (1997) Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. J Child Adolesc Psychopharmacol 7:17\u201329","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"644_CR43","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/archpedi.1988.02150110122036","volume":"142","author":"R Famularo","year":"1988","unstructured":"Famularo R, Kinscherff R, Fenton T (1988) Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study. Am J Dis Child 142:1244\u20131247","journal-title":"Am J Dis Child"},{"key":"644_CR44","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1176\/ajp.152.11.1586","volume":"152","author":"RF Ferdinand","year":"1995","unstructured":"Ferdinand RF, Verhulst FC (1995) Psychopathology from adolescence into young adulthood: an 8-year follow-up study. Am J Psychiatry 152:1586\u20131594","journal-title":"Am J Psychiatry"},{"key":"644_CR45","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archpsyc.1985.01790330057007","volume":"42","author":"MF Flament","year":"1985","unstructured":"Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellstrom B, Linnoila M (1985) Clomipramine treatment of childhood obsessive\u2013compulsive disorder. A double-blind controlled study. Arch Gen Psychiatry 42:977\u2013983","journal-title":"Arch Gen Psychiatry"},{"key":"644_CR46","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00004583-198811000-00018","volume":"27","author":"MF Flament","year":"1988","unstructured":"Flament MF, Whitaker A, Rapoport JL, Davies M, Berg CZ, Kalikow K, Sceery W, Shaffer D (1988) Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry 27:764\u2013771","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR47","unstructured":"Foa EB, Davidson JRT, Frances A (eds) (1999) The expert consensus guideline series. Treatment of posttraumatic stress disorder. The Expert Consensus Panels for PTSD. J Clin Psychiatry 16 (60 Suppl):3\u201376"},{"key":"644_CR48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/104454601750284090","volume":"11","author":"EJ Garland","year":"2001","unstructured":"Garland EJ, Baerg EA (2001) Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents. J Child Adolesc Psychopharmacol 11:181\u2013186","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"644_CR49","first-page":"511","volume-title":"Obsessive\u2013compulsive disorder. Pediatric psychopharmacology: principles and practice","author":"DA Geller","year":"2003","unstructured":"Geller DA, Spencer T (2003) Obsessive\u2013compulsive disorder. Pediatric psychopharmacology: principles and practice. Oxford University Press, New York, pp 511\u2013525"},{"key":"644_CR50","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00004583-200107000-00011","volume":"40","author":"DA Geller","year":"2001","unstructured":"Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S, Jacobson JG (2001) Fluoxetine treatment for obsessive\u2013compulsive disorder in children and adolescents: a placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry 40:773\u2013779","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"Suppl 1","key":"644_CR51","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/104454603322126313","volume":"13","author":"DA Geller","year":"2003","unstructured":"Geller DA, Biederman J, Stewart SE, Mullin B, Farrell C, Wagner KD, Emslie G, Carpenter D (2003a) Impact of comorbidity on treatment response to paroxetine in pediatric obsessive\u2013compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? J Child Adolesc Psychopharmacol 13 (Suppl 1):S19\u2013S29","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"644_CR52","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1176\/appi.ajp.160.11.1919","volume":"160","author":"DA Geller","year":"2003","unstructured":"Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV (2003b) Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive\u2013compulsive disorder. Am J Psychiatry 160:1919\u20131928","journal-title":"Am J Psychiatry"},{"key":"644_CR53","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/01.chi.0000138356.29099.f1","volume":"43","author":"DA Geller","year":"2004","unstructured":"Geller DA, Wagner KD, Emslie G, Murphy T, Carpenter DJ, Wetherhold E, Perera P, Machin A, Gardiner C (2004) Paroxetine treatment in children and adolescents with obsessive\u2013compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 43:1387\u20131396","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR54","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00004583-199510000-00023","volume":"34","author":"RM Giaconia","year":"1995","unstructured":"Giaconia RM, Reinherz HZ, Silverman AB, Pakiz B, Frost AK, Cohen E (1995) Traumas and posttraumatic stress disorder in a community population of older adolescents. J Am Acad Child Adolesc Psychiatry 34:1369\u20131380","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archpsyc.62.2.165","volume":"62","author":"RD Gibbons","year":"2005","unstructured":"Gibbons RD, Hur K, Bhaumik DK, Mann JJ (2005) The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 62:165\u2013172","journal-title":"Arch Gen Psychiatry"},{"key":"644_CR56","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/archpsyc.1971.01750150012002","volume":"25","author":"R Gittleman-Klein","year":"1971","unstructured":"Gittleman-Klein, R Klein D (1971) Controlled imipramine treatment of school phobia. Arch Gen Psychiatry 25:204\u2013207","journal-title":"Arch Gen Psychiatry"},{"key":"644_CR57","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00004583-199403000-00011","volume":"33","author":"F Graae","year":"1994","unstructured":"Graae F, Milner J, Rizzotto L, Klein RG (1994) Clonazepam in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 33:372\u2013376","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR58","unstructured":"Hammad T (2004) Review and evaluation of clinical data: Relationship between psychotropic drugs and pediatric suicidality. http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/briefing\/2004-4065b1-10-TAB08-Hammads-Review.pdf.2004"},{"key":"644_CR59","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/00004583-199609000-00022","volume":"35","author":"RJ Harmon","year":"1996","unstructured":"Harmon RJ, Riggs PD (1996) Clonidine for posttraumatic stress disorder in preschool children. J Am Acad Child Adolesc Psychiatry 35:1247\u20131249","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR60","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0193-953X(18)30217-X","volume":"15","author":"MA Jenike","year":"1992","unstructured":"Jenike MA (1992) Pharmacologic treatment of obsessive compulsive disorders. Psychiatr Clin North Am 15:895\u2013919","journal-title":"Psychiatr Clin North Am"},{"key":"644_CR61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00004583-200102000-00009","volume":"40","author":"PS Jensen","year":"2001","unstructured":"Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, March JS, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B (2001) ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 40:147\u2013158","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR62","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1207\/S15374424JCCP3003_4","volume":"30","author":"JB Kaplow","year":"2001","unstructured":"Kaplow JB, Curran PJ, Angold A, Costello EJ (2001) The prospective relation between dimensions of anxiety and the initiation of adolescent alcohol use. J Clin Child Psychol 30:316\u2013326","journal-title":"J Clin Child Psychol"},{"key":"644_CR63","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1176\/ajp.147.3.313","volume":"147","author":"JH Kashani","year":"1990","unstructured":"Kashani JH, Orvaschel H (1990) A community study of anxiety in children and adolescents. Am J Psychiatry 147:313\u2013318","journal-title":"Am J Psychiatry"},{"key":"644_CR64","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/00004583-200010000-00002","volume":"39","author":"J Kaufman","year":"2000","unstructured":"Kaufman J, Birmaher B, Brent DA, Ryan ND, Rao U (2000) K-SADS-PL. J Am Acad Child Adolesc Psychiatry 39:1208","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR65","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1037\/0022-006X.62.1.100","volume":"62","author":"PC Kendall","year":"1994","unstructured":"Kendall PC (1994) Treating anxiety disorders in children: results of a randomized clinical trial. J Consult Clin Psychol 62:100\u2013110","journal-title":"J Consult Clin Psychol"},{"key":"644_CR66","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1037\/0022-006X.65.3.366","volume":"65","author":"PC Kendall","year":"1997","unstructured":"Kendall PC, Flannery-Schroeder E, Panichelli-Mindel SM, Southam-Gerow M, Henin A, Warman M (1997) Therapy for youths with anxiety disorders: a second randomized clinical trial. J Consult Clin Psychol 65:366\u2013380","journal-title":"J Consult Clin Psychol"},{"key":"644_CR67","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00004583-200107000-00013","volume":"40","author":"PC Kendall","year":"2001","unstructured":"Kendall PC, Brady EU, Verduin TL (2001) Comorbidity in childhood anxiety disorders and treatment outcome. J Am Acad Child Adolesc Psychiatry 40:787\u2013794","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR68","volume-title":"Child and adolescent psychiatry: modern approaches","author":"R Klein","year":"1995","unstructured":"Klein R (1995) Anxiety disorders. In: Rutter M, Taylor E, Hersov L (eds) Child and adolescent psychiatry: modern approaches. Blackwell, London"},{"key":"644_CR69","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/00004583-199009000-00026","volume":"29","author":"DF Klein","year":"1990","unstructured":"Klein DF, Klein RG (1990) Does panic disorder exist in childhood? J Am Acad Child Adolesc Psychiatry 29:834\u2013835","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00004583-199201000-00005","volume":"31","author":"RG Klein","year":"1992","unstructured":"Klein RG, Koplewicz HS, Kanner A (1992) Imipramine treatment of children with separation anxiety disorder. J Am Acad Child Adolesc Psychiatry 31:21\u201328","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0193-953X(18)30257-0","volume":"15","author":"SP Kutcher","year":"1992","unstructured":"Kutcher SP, Reiter S, Gardner DM, Klein RG (1992) The pharmacotherapy of anxiety disorders in children and adolescents. Psychiatr Clin North Am 15:41\u201367","journal-title":"Psychiatr Clin North Am"},{"key":"644_CR72","first-page":"496","volume-title":"Pediatric psychopharmacology: principles and practice","author":"M Labellarte","year":"2003","unstructured":"Labellarte M, Ginsburg GS (2003) Anxiety disorders. In: Martin A, Scahill L, Charney D et al (eds) Pediatric psychopharmacology: principles and practice. Oxford University Press, New York, pp 496\u2013510"},{"key":"644_CR73","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0006-3223(99)00248-6","volume":"46","author":"MJ Labellarte","year":"1999","unstructured":"Labellarte MJ, Ginsburg GS, Walkup JT, Riddle MA (1999) The treatment of anxiety disorders in children and adolescents. Biol Psychiatry 46:1567\u20131578","journal-title":"Biol Psychiatry"},{"key":"644_CR74","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/00004583-199611000-00019","volume":"35","author":"CG Last","year":"1996","unstructured":"Last CG, Perrin S, Hersen M, Kazdin AE (1996) A prospective study of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 35:1502\u20131510","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR75","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4088\/JCP.v65n0706","volume":"65","author":"AC Leon","year":"2004","unstructured":"Leon AC, Marzuk PM, Tardiff K, Teres JJ (2004) Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998. J Clin Psychiatry 65:915\u2013918","journal-title":"J Clin Psychiatry"},{"key":"644_CR76","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/archpsyc.1989.01810120030006","volume":"46","author":"HL Leonard","year":"1989","unstructured":"Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL, Hamburger SD (1989) Treatment of obsessive\u2013compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. Arch Gen Psychiatry 46:1088\u20131092","journal-title":"Arch Gen Psychiatry"},{"key":"644_CR77","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.156.3772.258","volume":"156","author":"S Levine","year":"1967","unstructured":"Levine S (1967) Maternal and environmental influences on the adrenocortical response to stress in weanling rats. Science 156:258\u2013260","journal-title":"Science"},{"key":"644_CR78","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1126\/science.152.3729.1585","volume":"152","author":"S Levine","year":"1966","unstructured":"Levine S, Mullins RF Jr (1966) Hormonal influences on brain organization in infant rats. Science 152:1585\u20131592","journal-title":"Science"},{"key":"644_CR79","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0887-6185(97)00017-0","volume":"11","author":"PM Lewinsohn","year":"1997","unstructured":"Lewinsohn PM, Zinbarg R, Seeley JR, Lewinsohn M, Sack WH (1997) Lifetime comorbidity among anxiety disorders and between anxiety disorders and other mental disorders in adolescents. J Anxiety Disord 11:377\u2013394","journal-title":"J Anxiety Disord"},{"key":"644_CR80","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrd1634","volume":"4","author":"J Licinio","year":"2005","unstructured":"Licinio J, Wong ML (2005) Opinion: depression, antidepressants and suicidality: a critical appraisal. Nat Rev Drug Discov 4:165\u2013171","journal-title":"Nat Rev Drug Discov"},{"key":"644_CR81","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00004583-200212000-00014","volume":"41","author":"MR Liebowitz","year":"2002","unstructured":"Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO, Graae F, Jaffer M, Lin SH, Sallee FR, Schmidt AB, Simpson HB (2002) Fluoxetine in children and adolescents with OCD: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 41:1431\u20131438","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR82","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00004583-199506000-00008","volume":"34","author":"D Looff","year":"1995","unstructured":"Looff D, Grimley P, Kuller F, Martin A, Shonfield L (1995) Carbamazepine for PTSD. J Am Acad Child Adolesc Psychiatry 34:703\u2013704","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR83","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1520-6394(1999)10:1<18::AID-DA3>3.0.CO;2-R","volume":"10","author":"K Manassis","year":"1999","unstructured":"Manassis K, Menna R (1999) Depression in anxious children: possible factors in comorbidity. Depress Anxiety 10:18\u201324","journal-title":"Depress Anxiety"},{"key":"644_CR84","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004583-200101000-00024","volume":"40","author":"K Manassis","year":"2001","unstructured":"Manassis K, Monga S (2001) A therapeutic approach to children and adolescents with anxiety disorders and associated comorbid conditions. J Am Acad Child Adolesc Psychiatry 40:115\u2013117","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR85","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jama.280.20.1752","volume":"280","author":"JS March","year":"1998","unstructured":"March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, Cutler NR, Dominguez R, Ferguson J, Muller B, Riesenberg R, Rosenthal M, Sallee FR, Wagner KD, Steiner H (1998) Sertraline in children and adolescents with obsessive\u2013compulsive disorder: a multicenter randomized controlled trial. JAMA 280:1752\u20131756","journal-title":"JAMA"},{"key":"644_CR86","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1023\/A:1005179014321","volume":"28","author":"JS March","year":"2000","unstructured":"March JS, Swanson JM, Arnold LE, Hoza B, Conners CK, Hinshaw SP, Hechtman L, Kraemer HC, Greenhill LL, Abikoff HB, Elliott LG, Jensen PS, Newcorn JH, Vitiello B, Severe J, Wells KC, Pelham WE (2000) Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). J Abnorm Child Psychol 28:527\u2013541","journal-title":"J Abnorm Child Psychol"},{"key":"644_CR87","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1001948610318","volume":"31","author":"G Masi","year":"2000","unstructured":"Masi G, Favilla L, Mucci M, Millepiedi S (2000) Panic disorder in clinically referred children and adolescents. Child Psychiatry Hum Dev 31:139\u2013151","journal-title":"Child Psychiatry Hum Dev"},{"key":"644_CR88","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/0003-4819-126-9-199705010-00007","volume":"126","author":"HJ McQuay","year":"1997","unstructured":"McQuay HJ, Moore RA (1997) Using numerical results from systematic reviews in clinical practice. Ann Intern Med 126:712\u2013720","journal-title":"Ann Intern Med"},{"key":"644_CR89","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0010-440X(69)90031-5","volume":"10","author":"JG Mendel","year":"1969","unstructured":"Mendel JG, Klein DF (1969) Anxiety attacks with subsequent agoraphobia. Compr Psychiatry 10:190\u2013195","journal-title":"Compr Psychiatry"},{"key":"644_CR90","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0006-8993(00)02909-7","volume":"883","author":"SD Norrholm","year":"2000","unstructured":"Norrholm SD, Ouimet CC (2000) Chronic fluoxetine administration to juvenile rats prevents age-associated dendritic spine proliferation in hippocampus. Brain Res 883:205\u2013215","journal-title":"Brain Res"},{"key":"644_CR91","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archpsyc.60.9.978","volume":"60","author":"M Olfson","year":"2003","unstructured":"Olfson M, Shaffer D, Marcus SC, Greenberg T (2003) Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 60:978\u2013982","journal-title":"Arch Gen Psychiatry"},{"key":"644_CR92","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/ajp.152.1.76","volume":"152","author":"DL Pauls","year":"1995","unstructured":"Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman JF (1995) A family study of obsessive\u2013compulsive disorder. Am J Psychiatry 152:76\u201384","journal-title":"Am J Psychiatry"},{"key":"644_CR93","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","volume":"292","author":"Pediatric OCD Treatment Study (POTS) Team","year":"2004","unstructured":"Pediatric OCD Treatment Study (POTS) Team (2004) Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive\u2013compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292:1969\u20131976","journal-title":"JAMA"},{"key":"644_CR94","first-page":"233","volume-title":"Catecholamine function in posttraumatic stress disorder: emerging concepts","author":"BD Perry","year":"1994","unstructured":"Perry BD (1994) Neurobiological sequelae of childhood trauma: PTSD in children. In: Murburg MM (ed) Catecholamine function in posttraumatic stress disorder: emerging concepts. American Psychiatric Press, Washington, DC, pp 233\u2013255"},{"key":"644_CR95","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00004583-199402000-00019","volume":"33","author":"DS Pine","year":"1994","unstructured":"Pine DS (1994) Child\u2013adult anxiety disorders. J Am Acad Child Adolesc Psychiatry 33:280\u2013281","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR96","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/104454602760386888","volume":"12","author":"DS Pine","year":"2002","unstructured":"Pine DS (2002) Treating children and adolescents with selective serotonin reuptake inhibitors: how long is appropriate? J Child Adolesc Psychopharmacol 12:189\u2013203","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"644_CR97","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archpsyc.55.1.56","volume":"55","author":"DS Pine","year":"1998","unstructured":"Pine DS, Cohen P, Gurley D, Brook J, Ma Y (1998) The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 55:56\u201364","journal-title":"Arch Gen Psychiatry"},{"key":"644_CR98","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/00004583-200007000-00021","volume":"39","author":"SR Pliszka","year":"2000","unstructured":"Pliszka SR, Greenhill LL, Crismon ML, Sedillo A, Carlson C, Conners CK, McCracken JT, Swanson JM, Hughes CW, Llana ME, Lopez M, Toprac MG (2000) The Texas children\u2019s medication algorithm project: report of the Texas consensus conference panel on medication treatment of childhood attention-deficit\/hyperactivity disorder. Part I. Attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 39:908\u2013919","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR99","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4088\/JCP.v62n0508","volume":"62","author":"MH Pollack","year":"2001","unstructured":"Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK (2001) Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 62:350\u2013357","journal-title":"J Clin Psychiatry"},{"key":"644_CR100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/cap.2006.16.227","volume":"16","author":"SP Reinblatt","year":"2006","unstructured":"Reinblatt SP, Riddle MA (2006) Selective serotonin reuptake inhibitor-induced apathy: a pediatric case series. J Child Adolesc Psychopharmacol 16:227\u2013233","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"644_CR101","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.chc.2005.06.004","volume":"14","author":"SP Reinblatt","year":"2005","unstructured":"Reinblatt SP, Walkup JT (2005) Psychopharmacologic treatment of pediatric anxiety disorders. Child Adolesc Psychiatr Clin N Am 14:877\u2013908","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"644_CR102","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00004714-199108000-00016","volume":"11","author":"S Reiter","year":"1991","unstructured":"Reiter S, Kutcher SP (1991) Disinhibition and anger outbursts in adolescents treated with clonazepam. J Clin Psychopharmacol 11:268","journal-title":"J Clin Psychopharmacol"},{"key":"644_CR103","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/cap.1999.9.73","volume":"9","author":"J Renaud","year":"1999","unstructured":"Renaud J, Birmaher B, Wassick SC, Bridge J (1999) Use of selective serotonin reuptake inhibitors for the treatment of childhood panic disorder: a pilot study. J Child Adolesc Psychopharmacol 9:73\u201383","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"644_CR104","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM200104263441703","volume":"344","author":"Research Units for Pediatric Psychopharmacology (RUPP) Anxiety Study Group","year":"2001","unstructured":"Research Units for Pediatric Psychopharmacology (RUPP) Anxiety Study Group (2001) Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 344:1279\u20131285","journal-title":"N Engl J Med"},{"key":"644_CR105","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00004583-200209000-00006","volume":"41","author":"Research Units for Pediatric Psychopharmacology (RUPP) Anxiety Study Group","year":"2002","unstructured":"Research Units for Pediatric Psychopharmacology (RUPP) Anxiety Study Group (2002a) The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry 41:1061\u20131069","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR106","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/104454602760386879","volume":"12","author":"Research Units for Pediatric Psychopharmacology (RUPP) Anxiety Study Group","year":"2002","unstructured":"Research Units for Pediatric Psychopharmacology (RUPP) Anxiety Study Group (2002b) Treatment of pediatric anxiety disorders: an open-label extension of the Research Units on Pediatric Psychopharmacology Anxiety Study. J Child Adolesc Psychopharmacol 12:175\u2013188","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"644_CR107","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","volume":"61","author":"KJ Ressler","year":"2004","unstructured":"Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M (2004) Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61:1136\u20131144","journal-title":"Arch Gen Psychiatry"},{"key":"644_CR108","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/ajp.140.1.82","volume":"140","author":"K Rickels","year":"1983","unstructured":"Rickels K, Csanalosi I, Greisman P, Cohen D, Werblowsky J, Ross HA, Harris H (1983) A controlled clinical trial of alprazolam for the treatment of anxiety. Am J Psychiatry 140:82\u201385","journal-title":"Am J Psychiatry"},{"key":"644_CR109","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archpsyc.1990.01810220015002","volume":"47","author":"K Rickels","year":"1990","unstructured":"Rickels K, Schweizer E, Case WG, Greenblatt DJ (1990) Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry 47:899\u2013907","journal-title":"Arch Gen Psychiatry"},{"key":"644_CR110","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00004583-199211000-00011","volume":"31","author":"MA Riddle","year":"1992","unstructured":"Riddle MA, Scahill L, King RA, Hardin MT, Anderson GM, Ort SI, Smith JC, Leckman JF, Cohen DJ (1992) Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive\u2013compulsive disorder. J Am Acad Child Adolesc Psychiatry 31:1062\u20131069","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR111","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00004583-199905000-00016","volume":"38","author":"MA Riddle","year":"1999","unstructured":"Riddle MA, Bernstein GA, Cook EH, Leonard HL, March JS, Swanson JM (1999) Anxiolytics, adrenergic agents, and naltrexone. J Am Acad Child Adolesc Psychiatry 38:546\u2013556","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR112","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00004583-200102000-00017","volume":"40","author":"MA Riddle","year":"2001","unstructured":"Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghorn JL, Gaffney G, Greist JH, Holland D, McConville BJ, Pigott T, Walkup JT (2001) Fluvoxamine for children and adolescents with obsessive\u2013compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry 40:222\u2013229","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR113","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00004583-199907000-00018","volume":"38","author":"R Robert","year":"1999","unstructured":"Robert R, Blakeney PE, Villarreal C, Rosenberg L, Meyer WJ, III (1999) Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study. J Am Acad Child Adolesc Psychiatry 38:873\u2013882","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR114","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1001\/archpedi.155.5.560","volume":"155","author":"JL Rushton","year":"2001","unstructured":"Rushton JL, Whitmire JT (2001) Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Arch Pediatr Adolesc Med 155:560\u2013565","journal-title":"Arch Pediatr Adolesc Med"},{"key":"644_CR115","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1176\/appi.ajp.158.12.2008","volume":"158","author":"MA Rynn","year":"2001","unstructured":"Rynn MA, Siqueland L, Rickels K (2001) Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry 158:2008\u20132014","journal-title":"Am J Psychiatry"},{"key":"644_CR116","doi-asserted-by":"crossref","unstructured":"Rynn MN, Riddle MA, Yeung PP, Kunz NR (2007) Efficacy and safety of venlafaxine ER in the treatment of children and adolescents with generalized anxiety disorder: two placebo-controlled trials. Am J Psychiatry (in press)","DOI":"10.1176\/ajp.2007.164.2.290"},{"key":"644_CR117","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1542\/peds.2006-0215","volume":"118","author":"DJ Safer","year":"2006","unstructured":"Safer DJ (2006) Should selective serotonin reuptake inhibitors be prescribed for children with major depressive and anxiety disorders? Pediatrics 118:1248\u20131251","journal-title":"Pediatrics"},{"key":"644_CR118","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/01.chi.0000131135.70992.58","volume":"43","author":"AM Scharko","year":"2004","unstructured":"Scharko AM (2004) Selective serotonin reuptake inhibitor-induced sexual dysfunction in adolescents: a review. J Am Acad Child Adolesc Psychiatry 43:1071\u20131079","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR119","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.chi.0000132832.05219.65","volume":"43","author":"AM Scharko","year":"2004","unstructured":"Scharko AM, Reiner WG (2004) SSRI-induced sexual dysfunction in adolescents. J Am Acad Child Adolesc Psychiatry 43:1067\u20131068","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR120","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1176\/ajp.151.12.1723","volume":"151","author":"MA Schuckit","year":"1994","unstructured":"Schuckit MA, Hesselbrock V (1994) Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry 151:1723\u20131734","journal-title":"Am J Psychiatry"},{"key":"644_CR121","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jama.287.9.1103-JFD20003-3-1","volume":"287","author":"BA Schwetz","year":"2002","unstructured":"Schwetz BA (2002) From the food and drug administration. JAMA 287:1103","journal-title":"JAMA"},{"key":"644_CR122","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00004583-200001000-00014","volume":"39","author":"D Shaffer","year":"2000","unstructured":"Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME (2000) NIMH Diagnostic interview schedule for children version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 39:28\u201338","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR123","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004583-199201000-00006","volume":"31","author":"JG Simeon","year":"1992","unstructured":"Simeon JG, Ferguson HB, Knott V, Roberts N, Gauthier B, Dubois C, Wiggins D (1992) Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry 31:29\u201333","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/appi.ajp.163.1.41","volume":"163","author":"GE Simon","year":"2006","unstructured":"Simon GE, Savarino J, Operskalski B, Wang PS (2006) Suicide risk during antidepressant treatment. Am J Psychiatry 163:41\u201347","journal-title":"Am J Psychiatry"},{"key":"644_CR125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4088\/JCP.v64n0305","volume":"64","author":"F Stocchi","year":"2003","unstructured":"Stocchi F, Nordera G, Jokinen RH, Lepola UM, Hewett K, Bryson H, Iyengar MK (2003) Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder. J Clin Psychiatry 64:250\u2013258","journal-title":"J Clin Psychiatry"},{"key":"644_CR126","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archpsyc.1994.03950070051010","volume":"51","author":"GD Tollefson","year":"1994","unstructured":"Tollefson GD, Rampey AH Jr, Potvin JH, Jenike MA, Rush AJ, kominguez RA, Koran LM, Shear MK, Goodman W, Genduso LA (1994) A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive\u2013compulsive disorder. Arch Gen Psychiatry 51:559\u2013567","journal-title":"Arch Gen Psychiatry"},{"key":"644_CR127","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1176\/appi.ajp.161.1.3","volume":"161","author":"RJ Ursano","year":"2004","unstructured":"Ursano RJ, Bell C, Eth S, Friedman M, Norwood A, Pfefferbaum B, Pynoos JD, Zatzick DF, Benedek DM, McIntyre JS, Charles SC, Altshuler K, Cook I, Cross CD, Mellman L, Moench LA, Norquist G, Twemlow SW, Woods S, Yager J (2004) Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am J Psychiatry 161:3\u201331","journal-title":"Am J Psychiatry"},{"key":"644_CR128","unstructured":"US Food and Drug Administration. FDA recommendation for black box warning. online 2-3-2005; http:\/\/www.fda.gov\/cder\/drug\/antidepressants.PL_template.pdf."},{"key":"644_CR129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1056-4993(18)30138-X","volume":"9","author":"JF Velosa","year":"2000","unstructured":"Velosa JF, Riddle MA (2000) Pharmacologic treatment of anxiety disorders in children and adolescents. Child Adolesc Psychiatr Clin N Am 9:119\u2013133","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"644_CR130","first-page":"1090","volume":"148","author":"R Viswanathan","year":"1991","unstructured":"Viswanathan R, Paradis C (1991) Treatment of cancer phobia with fluoxetine. Am J Psychiatry 148:1090","journal-title":"Am J Psychiatry"},{"key":"644_CR131","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/00004583-199009000-00017","volume":"29","author":"B Vitiello","year":"1990","unstructured":"Vitiello B, Behar D, Wolfson S, McLeer SV (1990) Diagnosis of panic disorder in prepubertal children. J Am Acad Child Adolesc Psychiatry 29:782\u2013784","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"644_CR132","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archpsyc.61.11.1153","volume":"61","author":"KD Wagner","year":"2004","unstructured":"Wagner KD, Berard R, Stein MB, Wetherhold E, Carpenter DJ, Perera P, Gee M, Davy K, Machin A (2004) A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Arch Gen Psychiatry 61:1153\u20131162","journal-title":"Arch Gen Psychiatry"},{"key":"644_CR133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/104454601750143320","volume":"11","author":"J Walkup","year":"2001","unstructured":"Walkup J, Labellarte M (2001) Complications of SSRI treatment. J Child Adolesc Psychopharmacol 11:1\u20134","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"644_CR134","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.chc.2005.08.009","volume":"15","author":"B Waslick","year":"2006","unstructured":"Waslick B (2006) Psychopharmacology interventions for pediatric anxiety disorders: a research update. Child Adolesc Psychiatr Clin N Am 15:51\u201371","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"644_CR135","volume-title":"Child and adolescent clinical psychopharmacology","author":"WH Green","year":"1997","unstructured":"Green WH (1997) Child and adolescent clinical psychopharmacology, 3rd edn. Williams & Wilkins, Philadelphia","edition":"3"},{"key":"644_CR136","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/cap.1999.9.13","volume":"9","author":"V Wegerer","year":"1999","unstructured":"Wegerer V, Moll GH, Bagli M, Rothenberger A, Ruther E, Huether G (1999) Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life. J Child Adolesc Psychopharmacol 9:13\u201324","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"644_CR137","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archpsyc.56.9.794","volume":"56","author":"MM Weissman","year":"1999","unstructured":"Weissman MM, Wolk S, Wickramaratne P, Goldstein RB, Adams P, Greenwald S, Ryan ND, Dahl RE, Steinberg D (1999) Children with prepubertal-onset major depressive disorder and anxiety grown up. Arch Gen Psychiatry 56:794\u2013801","journal-title":"Arch Gen Psychiatry"},{"key":"644_CR138","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/00004583-199507000-00008","volume":"34","author":"HH Wright","year":"1995","unstructured":"Wright HH, Cuccaro ML, Leonhardt TV, Kendall DF, Anderson JH (1995) Case study: fluoxetine in the multimodal treatment of a preschool child with selective mutism. J Am Acad Child Adolesc Psychiatry 34:857\u2013862","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0644-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-006-0644-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0644-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:31:32Z","timestamp":1558629092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-006-0644-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,5]]},"references-count":138,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2,15]]}},"alternative-id":["644"],"URL":"https:\/\/doi.org\/10.1007\/s00213-006-0644-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,5]]}}}